ClinicalTrialsFinder

ALK Gene Mutation Clinical Trials in Mexico City, Mexico City

1 recruitingMexico City, Mexico City, Mexico

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene MutationNon-small Cell Lung Cancer Stage IIIB
Instituto Nacional de Cancerologia de Mexico45 enrolled1 locationNCT05713006